Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in Cuba

Not Applicable

Completed

• Conditions: Poliomyelitis vaccination; Infections and Infestations; Poliomyelitis

• Registration Number: ISRCTN19673867
• Lead Sponsor: World Health Organization (WHO) (Switzerland)

Brief Summary

2013 Results article in https://pubmed.ncbi.nlm.nih.gov/23363495/ results (added 30/09/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2007-04-30
• Study Start: 2007-08-15
• Last Update Posted: 11 October 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 320

Inclusion Criteria

1. Healthy newborns (greater than 2.5 kg, apgar score greater than 9 at five minutes)
2. Living within the catchment area of the participating polyclinics
3. Newborns delivered by caesarian section

Exclusion Criteria

1. Newborns requiring hospitalisation (except if in hospital because of maternal admission)
2. Birth weight below 2.5 kg
3. Apgar score less than 9
4. Residence outside the catchment area, or families expecting to move away during the study period
5. A diagnosis or suspicion of immunodeficiency disorder (either in the participant or in a member of the immediate family) will also render the newborn ineligible for the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified